000 01334nam a2200373 a 4500
005 20250914094636.0
008 001122m1999 frea 000 0 eng b
020 _a3540596666
_cRM382.14
039 9 _a200011231627
_bpuitm
_c200011221520
_dpuitm
_y11-22-2000
_zpuitm
040 _dUKM
_erda
060 _aQZ276
090 _aQZ267
_b.P9635 1999 9HUKM
245 0 0 _aProgress in anti-cancer chemotheraphy /
_cedited by Gabriel N. Hortobagyi, David Khayat
260 _aParis :
_bSpringer,
_c1999
300 _a3 volume, 304 pages :
_billustrations ;
_c25 cm.
336 _atext
_2rdacontent
337 _aunmediated
_2rdamedia
338 _avolume
_2rdacarrier
490 1 _aProgress in Anti-Cancer Chemotheraphy (
_vvolume 3).
650 2 _aNeoplasms
_xDrug therapy.
650 2 _aNeoplasms
_xImmunology.
650 2 _aAntineoplastics agents
_xtherapeutic use.
650 2 _aChemoprevention
_xmethods.
700 1 _aHortobagyi, Gabriel N.,
_eeditor.
700 1 _aKhayat, David
_eeditor.
830 0 _aProgress in Anti-Cancer Chemotheraphy (
_vvolume 3).
907 _a.b12765879
_b2021-03-26
_c2019-11-12
942 _c01
_n0
_kQZ267 .P9635 1999 9HUKM
914 _avtls000286130
990 _aharisom/Nazmi.
991 _aJabatan Perubatan, HUKM
998 _ah
_b2000-09-11
_cm
_da
_feng
_g
_y0
_z.b12765879
999 _c277256
_d277256